Literature DB >> 12441845

Ocular manifestations of systemic lupus erythematosus.

J Fernando Arevalo1, Careen Y Lowder, Rafael Muci-Mendoza.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic, immunologic disorder that may affect multiple organ systems. Keratoconjunctivitis sicca is the most common ocular manifestation, but visual morbidity is usually due to retinal and neuro-ophthalmic manifestations of the disease. Ocular manifestations of lupus are a reflection of systemic disease. The presence of ocular manifestations should alert the clinician to the likely presence of disease activity elsewhere. Therefore, all patients with ocular lupus should be carefully evaluated for systemic involvement to detect potentially treatable and preventable complications of the disease. In addition, the ophthalmologist should include SLE in the differential diagnosis of many retinal vascular and neuro-ophthalmic disorders. The ophthalmologist may play an important role in the care of patients with SLE, since ocular inflammatory lesions may precede potentially serious extraocular disease.

Entities:  

Mesh:

Year:  2002        PMID: 12441845     DOI: 10.1097/00055735-200212000-00011

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  16 in total

1.  Manifestations of systemic lupus erythematosus.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2011-10

2.  Ocular manifestation of systemic lupus erythematosus.

Authors:  Rawhya R El-Shereef; Ahmad Shawkat Mohamed; Lamiaa Hamdy
Journal:  Rheumatol Int       Date:  2011-12-28       Impact factor: 2.631

3.  Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature.

Authors:  Rachel G Simpson; Majid Moshirfar; Jason N Edmonds; Steven M Christiansen; Nicholas Behunin
Journal:  Clin Ophthalmol       Date:  2012-11-05

4.  Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Authors:  Barbara M Wirostko; Charles Tressler; Lie-Ju Hwang; Gary Burgess; Alan M Laties
Journal:  BMJ       Date:  2012-02-21

5.  Retinal vasculitis in systemic lupus erythematosus: an indication of active disease.

Authors:  Umi Kalthum Md Noh; Aida Zairani A Zahidin; Then Kong Yong
Journal:  Clin Pract       Date:  2012-05-15

6.  Bilateral intravitreal ranibizumab injection and panretinal photocoagulation in a 16-year-old girl with severe vaso-occlusive lupus retinopathy.

Authors:  Hasan Can Doruk; Pinar Cetin; Fatos Onen; A Osman Saatci
Journal:  Case Rep Ophthalmol Med       Date:  2013-12-09

7.  Antiphospholipid syndrome in lupus retinopathy.

Authors:  Ng Hong-Kee; Chong Mei-Fong; Yaakub Azhany; Embong Zunaina
Journal:  Clin Ophthalmol       Date:  2014-11-24

8.  Unilateral macular edema with central retinal vein occlusion in systemic lupus erythematosus: a case report.

Authors:  Hidetaka Noma; Hiroshi Shimizu; Tatsuya Mimura
Journal:  Clin Ophthalmol       Date:  2013-05-09

9.  An unusual presentation of lupus retinopathy.

Authors:  Dinesh K Sahu
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

10.  Bilateral macular infarction as an ocular manifestation of systemic lupus erythematosus (SLE).

Authors:  Chih-Ling Hu; Kai-Ling Peng
Journal:  Clin Ophthalmol       Date:  2014-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.